サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1452064

天然の抗腫瘍薬の世界市場に関する洞察、2030年までの予測

Global Natural Antitumor Drug Market Insights, Forecast to 2030
出版日: | 発行: QYResearch | ページ情報: 英文 115 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
天然の抗腫瘍薬の世界市場に関する洞察、2030年までの予測
出版日: 2024年03月18日
発行: QYResearch
ページ情報: 英文 115 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、天然の抗腫瘍薬 (Natural Antitumor Drug) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 天然の抗腫瘍薬の製品概要
  • 市場：タイプ別
    • 世界の天然の抗腫瘍薬の市場規模成長率：タイプ別, 2019 VS 2023 VS 2030
    • Taxanes
    • Catharanthus Roseus
    • Podophyllotoxins
    • Colchicines
    • Others
  • 市場：用途別
    • 世界の天然の抗腫瘍薬の市場規模成長率：用途別, 2019 VS 2023 VS 2030
    • Breast Cancer
    • Stomach Cancer
    • Ovarian Cancer
    • Lung Cancer
    • Testicular Cancer
    • Cervical Cancer
    • Endometrial Cancer
    • Prostate Cancer
    • Bladder Cancer
    • Others
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の天然の抗腫瘍薬 売上予測・予想 2019-2030
  • 世界の天然の抗腫瘍薬の収益：地域別
    • 世界の天然の抗腫瘍薬の収益：地域別: 2019 VS 2023 VS 2030
    • 世界の天然の抗腫瘍薬の収益：地域別 (2019-2024)
    • 世界の天然の抗腫瘍薬の収益：地域別 (2025-2030)
    • 世界の天然の抗腫瘍薬の収益市場シェア 地域別 (2019-2030)
  • 世界の天然の抗腫瘍薬 売上予測・予想 2019-2030
  • 世界の天然の抗腫瘍薬の販売：地域別
    • 世界の天然の抗腫瘍薬の販売：地域別: 2019 VS 2023 VS 2030
    • 世界の天然の抗腫瘍薬の販売：地域別 (2019-2024)
    • 世界の天然の抗腫瘍薬の販売：地域別 (2025-2030)
    • 世界の天然の抗腫瘍薬の販売市場シェア 地域別 (2019-2030)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

  • 世界の天然の抗腫瘍薬の販売：企業別
    • 世界の天然の抗腫瘍薬の販売：企業別 (2019-2024)
    • 世界の天然の抗腫瘍薬の販売市場シェア：企業別 (2019-2024)
    • 世界の上位10・上位5企業： 天然の抗腫瘍薬 in 2023
  • 世界の天然の抗腫瘍薬の収益：企業別
    • 世界の天然の抗腫瘍薬の収益：企業別 (2019-2024)
    • 世界の天然の抗腫瘍薬の収益市場シェア：企業別 (2019-2024)
    • 世界の上位10・上位5企業： 天然の抗腫瘍薬の収益 2023
  • 世界の主要企業 天然の抗腫瘍薬, 業界ランキング, 2022 VS 2023 VS 2024
  • 世界の天然の抗腫瘍薬の販売価格：企業別
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界の天然の抗腫瘍薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー 天然の抗腫瘍薬, 製造拠点分布と本社
  • 世界の主要メーカー 天然の抗腫瘍薬, 提供製品と用途
  • 世界の主要メーカー 天然の抗腫瘍薬, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界の天然の抗腫瘍薬の販売：タイプ別
    • 世界の天然の抗腫瘍薬の販売実績：タイプ別 (2019-2024)
    • 世界の天然の抗腫瘍薬の販売予測：タイプ別 (2025-2030)
    • 世界の天然の抗腫瘍薬の販売市場シェア：タイプ別 (2019-2030)
  • 世界の天然の抗腫瘍薬 収益：タイプ別
    • 世界の天然の抗腫瘍薬の収益実績：タイプ別 (2019-2024)
    • 世界の天然の抗腫瘍薬の収益予測：タイプ別 (2025-2030)
    • 世界の天然の抗腫瘍薬の収益市場シェア：タイプ別 (2019-2030)
  • 世界の天然の抗腫瘍薬の価格：タイプ別
    • 世界の天然の抗腫瘍薬の価格：タイプ別 (2019-2024)
    • 世界の天然の抗腫瘍薬の価格予測：タイプ別 (2025-2030)

第5章 市場規模：用途別

  • 世界の天然の抗腫瘍薬の販売：用途別
    • 世界の天然の抗腫瘍薬の販売実績：用途別 (2019-2024)
    • 世界の天然の抗腫瘍薬の販売予測：用途別 (2025-2030)
    • 世界の天然の抗腫瘍薬の販売市場シェア：用途別 (2019-2030)
  • 世界の天然の抗腫瘍薬の収益：用途別
    • 世界の天然の抗腫瘍薬の収益実績：用途別 (2019-2024)
    • 世界の天然の抗腫瘍薬の収益予測：用途別 (2025-2030)
    • 世界の天然の抗腫瘍薬の収益市場シェア：用途別 (2019-2030)
  • 世界の天然の抗腫瘍薬の価格：用途別
    • 世界の天然の抗腫瘍薬の価格：用途別 (2019-2024)
    • 世界の天然の抗腫瘍薬の価格予測：用途別 (2025-2030)

第6章 米国・カナダ

  • 米国・カナダ 天然の抗腫瘍薬 市場規模：タイプ別
    • 米国・カナダ 天然の抗腫瘍薬の販売：タイプ別 (2019-2030)
    • 米国・カナダ 天然の抗腫瘍薬 収益：タイプ別 (2019-2030)
  • 米国・カナダ 天然の抗腫瘍薬 市場規模：用途別
    • 米国・カナダ 天然の抗腫瘍薬の販売：用途別 (2019-2030)
    • 米国・カナダ 天然の抗腫瘍薬の収益：用途別 (2019-2030)
  • 米国・カナダ 天然の抗腫瘍薬 市場規模：国別
    • 米国・カナダ 天然の抗腫瘍薬の収益：国別: 2019 VS 2023 VS 2030
    • 米国・カナダ 天然の抗腫瘍薬の販売：国別 (2019-2030)
    • 米国・カナダ 天然の抗腫瘍薬の収益：国別 (2019-2030)
    • US
    • カナダ

第7章 欧州

  • 欧州の天然の抗腫瘍薬 市場規模：タイプ別
    • 欧州の天然の抗腫瘍薬の販売：タイプ別 (2019-2030)
    • 欧州の天然の抗腫瘍薬 収益：タイプ別 (2019-2030)
  • 欧州の天然の抗腫瘍薬 市場規模：用途別
    • 欧州の天然の抗腫瘍薬の販売：用途別 (2019-2030)
    • 欧州の天然の抗腫瘍薬の収益：用途別 (2019-2030)
  • 欧州の天然の抗腫瘍薬 市場規模：国別
    • 欧州の天然の抗腫瘍薬の収益：国別: 2019 VS 2023 VS 2030
    • 欧州の天然の抗腫瘍薬の販売：国別 (2019-2030)
    • 欧州の天然の抗腫瘍薬の収益：国別 (2019-2030)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • オランダ

第8章 中国

  • 中国の天然の抗腫瘍薬 市場規模
    • 中国の天然の抗腫瘍薬 売上 (2019-2030)
    • 中国の天然の抗腫瘍薬 収益 (2019-2030)
  • 中国の天然の抗腫瘍薬 市場規模：用途別
    • 中国の天然の抗腫瘍薬の販売：用途別 (2019-2030)
    • 中国の天然の抗腫瘍薬の収益：用途別 (2019-2030)

第9章 アジア（中国を除く）

  • アジア地域 天然の抗腫瘍薬 市場規模：タイプ別
    • アジア地域 天然の抗腫瘍薬の販売：タイプ別 (2019-2030)
    • アジア地域 天然の抗腫瘍薬 収益：タイプ別 (2019-2030)
  • アジア地域 天然の抗腫瘍薬 市場規模：用途別
    • アジア地域 天然の抗腫瘍薬の販売：用途別 (2019-2030)
    • アジア地域 天然の抗腫瘍薬の収益：用途別 (2019-2030)
  • アジア地域 天然の抗腫瘍薬の販売：地域別
    • アジア地域 天然の抗腫瘍薬の収益：地域別: 2019 VS 2023 VS 2030
    • アジア地域 天然の抗腫瘍薬の収益：地域別 (2019-2030)
    • アジア地域 天然の抗腫瘍薬の販売：地域別 (2019-2030)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカの天然の抗腫瘍薬 市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカの天然の抗腫瘍薬の販売：タイプ別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの天然の抗腫瘍薬 収益：タイプ別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの天然の抗腫瘍薬 市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカの天然の抗腫瘍薬の販売：用途別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの天然の抗腫瘍薬の収益：用途別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの天然の抗腫瘍薬の販売：国別
    • 中東, アフリカ ・ラテンアメリカの天然の抗腫瘍薬の収益：国別: 2019 VS 2023 VS 2030
    • 中東, アフリカ ・ラテンアメリカの天然の抗腫瘍薬の収益：国別 (2019-2030)
    • 中東, アフリカ ・ラテンアメリカの天然の抗腫瘍薬の販売：国別 (2019-2030)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • Pfizer
  • Sanofi US
  • Sun Pharma
  • Oasmia
  • Indena
  • Bristol-Myers Squibb Company
  • PierreFabre
  • Qilu Pharmaceutical
  • Fuxing Medicine
  • Yuekang Pharmaceutical
  • Hengrui Medicine
  • Huiyu Pharmaceutical
  • Zhendong Pharmaceutical
  • Chinese Academy of Sciences
  • Hainan Changchun Pharmaceutical Co., Ltd.

第12章 業界チェーンと販売チャネルの分析

  • 天然の抗腫瘍薬 業界チェーン分析
  • 天然の抗腫瘍薬 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • 天然の抗腫瘍薬 生産形態とプロセス
  • 天然の抗腫瘍薬 販売およびマーケティング
    • 天然の抗腫瘍薬 販売チャネルs
    • 天然の抗腫瘍薬 卸業者
  • 天然の抗腫瘍薬 顧客

第13章 市場動向

  • 天然の抗腫瘍薬 業界動向
  • 天然の抗腫瘍薬 市場の促進要因
  • 天然の抗腫瘍薬 市場の課題
  • 天然の抗腫瘍薬 市場の抑制要因

第14章 主な調査結果 世界の天然の抗腫瘍薬の主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Natural Antitumor Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 2. Major Manufacturers of Taxanes
  • Table 3. Major Manufacturers of Catharanthus Roseus
  • Table 4. Major Manufacturers of Podophyllotoxins
  • Table 5. Major Manufacturers of Colchicines
  • Table 6. Major Manufacturers of Others
  • Table 7. Global Natural Antitumor Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 8. Global Natural Antitumor Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 9. Global Natural Antitumor Drug Revenue by Region (2019-2024) & (US$ Million)
  • Table 10. Global Natural Antitumor Drug Revenue by Region (2025-2030) & (US$ Million)
  • Table 11. Global Natural Antitumor Drug Revenue Market Share by Region (2019-2024)
  • Table 12. Global Natural Antitumor Drug Revenue Market Share by Region (2025-2030)
  • Table 13. Global Natural Antitumor Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 14. Global Natural Antitumor Drug Sales by Region (2019-2024) & (K Units)
  • Table 15. Global Natural Antitumor Drug Sales by Region (2025-2030) & (K Units)
  • Table 16. Global Natural Antitumor Drug Sales Market Share by Region (2019-2024)
  • Table 17. Global Natural Antitumor Drug Sales Market Share by Region (2025-2030)
  • Table 18. Global Natural Antitumor Drug Sales by Manufacturers (2019-2024) & (K Units)
  • Table 19. Global Natural Antitumor Drug Sales Share by Manufacturers (2019-2024)
  • Table 20. Global Natural Antitumor Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
  • Table 21. Global Natural Antitumor Drug Revenue Share by Manufacturers (2019-2024)
  • Table 22. Global Key Players of Natural Antitumor Drug, Industry Ranking, 2022 VS 2023 VS 2024
  • Table 23. Natural Antitumor Drug Price by Manufacturers 2019-2024 (US$/Unit)
  • Table 24. Global Natural Antitumor Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 25. Global Natural Antitumor Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Antitumor Drug as of 2023)
  • Table 26. Global Key Manufacturers of Natural Antitumor Drug, Manufacturing Base Distribution and Headquarters
  • Table 27. Global Key Manufacturers of Natural Antitumor Drug, Product Offered and Application
  • Table 28. Global Key Manufacturers of Natural Antitumor Drug, Date of Enter into This Industry
  • Table 29. Mergers & Acquisitions, Expansion Plans
  • Table 30. Global Natural Antitumor Drug Sales by Type (2019-2024) & (K Units)
  • Table 31. Global Natural Antitumor Drug Sales by Type (2025-2030) & (K Units)
  • Table 32. Global Natural Antitumor Drug Sales Share by Type (2019-2024)
  • Table 33. Global Natural Antitumor Drug Sales Share by Type (2025-2030)
  • Table 34. Global Natural Antitumor Drug Revenue by Type (2019-2024) & (US$ Million)
  • Table 35. Global Natural Antitumor Drug Revenue by Type (2025-2030) & (US$ Million)
  • Table 36. Global Natural Antitumor Drug Revenue Share by Type (2019-2024)
  • Table 37. Global Natural Antitumor Drug Revenue Share by Type (2025-2030)
  • Table 38. Natural Antitumor Drug Price by Type (2019-2024) & (US$/Unit)
  • Table 39. Global Natural Antitumor Drug Price Forecast by Type (2025-2030) & (US$/Unit)
  • Table 40. Global Natural Antitumor Drug Sales by Application (2019-2024) & (K Units)
  • Table 41. Global Natural Antitumor Drug Sales by Application (2025-2030) & (K Units)
  • Table 42. Global Natural Antitumor Drug Sales Share by Application (2019-2024)
  • Table 43. Global Natural Antitumor Drug Sales Share by Application (2025-2030)
  • Table 44. Global Natural Antitumor Drug Revenue by Application (2019-2024) & (US$ Million)
  • Table 45. Global Natural Antitumor Drug Revenue by Application (2025-2030) & (US$ Million)
  • Table 46. Global Natural Antitumor Drug Revenue Share by Application (2019-2024)
  • Table 47. Global Natural Antitumor Drug Revenue Share by Application (2025-2030)
  • Table 48. Natural Antitumor Drug Price by Application (2019-2024) & (US$/Unit)
  • Table 49. Global Natural Antitumor Drug Price Forecast by Application (2025-2030) & (US$/Unit)
  • Table 50. US & Canada Natural Antitumor Drug Sales by Type (2019-2024) & (K Units)
  • Table 51. US & Canada Natural Antitumor Drug Sales by Type (2025-2030) & (K Units)
  • Table 52. US & Canada Natural Antitumor Drug Revenue by Type (2019-2024) & (US$ Million)
  • Table 53. US & Canada Natural Antitumor Drug Revenue by Type (2025-2030) & (US$ Million)
  • Table 54. US & Canada Natural Antitumor Drug Sales by Application (2019-2024) & (K Units)
  • Table 55. US & Canada Natural Antitumor Drug Sales by Application (2025-2030) & (K Units)
  • Table 56. US & Canada Natural Antitumor Drug Revenue by Application (2019-2024) & (US$ Million)
  • Table 57. US & Canada Natural Antitumor Drug Revenue by Application (2025-2030) & (US$ Million)
  • Table 58. US & Canada Natural Antitumor Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 59. US & Canada Natural Antitumor Drug Revenue by Country (2019-2024) & (US$ Million)
  • Table 60. US & Canada Natural Antitumor Drug Revenue by Country (2025-2030) & (US$ Million)
  • Table 61. US & Canada Natural Antitumor Drug Sales by Country (2019-2024) & (K Units)
  • Table 62. US & Canada Natural Antitumor Drug Sales by Country (2025-2030) & (K Units)
  • Table 63. Europe Natural Antitumor Drug Sales by Type (2019-2024) & (K Units)
  • Table 64. Europe Natural Antitumor Drug Sales by Type (2025-2030) & (K Units)
  • Table 65. Europe Natural Antitumor Drug Revenue by Type (2019-2024) & (US$ Million)
  • Table 66. Europe Natural Antitumor Drug Revenue by Type (2025-2030) & (US$ Million)
  • Table 67. Europe Natural Antitumor Drug Sales by Application (2019-2024) & (K Units)
  • Table 68. Europe Natural Antitumor Drug Sales by Application (2025-2030) & (K Units)
  • Table 69. Europe Natural Antitumor Drug Revenue by Application (2019-2024) & (US$ Million)
  • Table 70. Europe Natural Antitumor Drug Revenue by Application (2025-2030) & (US$ Million)
  • Table 71. Europe Natural Antitumor Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 72. Europe Natural Antitumor Drug Revenue by Country (2019-2024) & (US$ Million)
  • Table 73. Europe Natural Antitumor Drug Revenue by Country (2025-2030) & (US$ Million)
  • Table 74. Europe Natural Antitumor Drug Sales by Country (2019-2024) & (K Units)
  • Table 75. Europe Natural Antitumor Drug Sales by Country (2025-2030) & (K Units)
  • Table 76. China Natural Antitumor Drug Sales by Type (2019-2024) & (K Units)
  • Table 77. China Natural Antitumor Drug Sales by Type (2025-2030) & (K Units)
  • Table 78. China Natural Antitumor Drug Revenue by Type (2019-2024) & (US$ Million)
  • Table 79. China Natural Antitumor Drug Revenue by Type (2025-2030) & (US$ Million)
  • Table 80. China Natural Antitumor Drug Sales by Application (2019-2024) & (K Units)
  • Table 81. China Natural Antitumor Drug Sales by Application (2025-2030) & (K Units)
  • Table 82. China Natural Antitumor Drug Revenue by Application (2019-2024) & (US$ Million)
  • Table 83. China Natural Antitumor Drug Revenue by Application (2025-2030) & (US$ Million)
  • Table 84. Asia Natural Antitumor Drug Sales by Type (2019-2024) & (K Units)
  • Table 85. Asia Natural Antitumor Drug Sales by Type (2025-2030) & (K Units)
  • Table 86. Asia Natural Antitumor Drug Revenue by Type (2019-2024) & (US$ Million)
  • Table 87. Asia Natural Antitumor Drug Revenue by Type (2025-2030) & (US$ Million)
  • Table 88. Asia Natural Antitumor Drug Sales by Application (2019-2024) & (K Units)
  • Table 89. Asia Natural Antitumor Drug Sales by Application (2025-2030) & (K Units)
  • Table 90. Asia Natural Antitumor Drug Revenue by Application (2019-2024) & (US$ Million)
  • Table 91. Asia Natural Antitumor Drug Revenue by Application (2025-2030) & (US$ Million)
  • Table 92. Asia Natural Antitumor Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 93. Asia Natural Antitumor Drug Revenue by Region (2019-2024) & (US$ Million)
  • Table 94. Asia Natural Antitumor Drug Revenue by Region (2025-2030) & (US$ Million)
  • Table 95. Asia Natural Antitumor Drug Sales by Region (2019-2024) & (K Units)
  • Table 96. Asia Natural Antitumor Drug Sales by Region (2025-2030) & (K Units)
  • Table 97. Middle East, Africa and Latin America Natural Antitumor Drug Sales by Type (2019-2024) & (K Units)
  • Table 98. Middle East, Africa and Latin America Natural Antitumor Drug Sales by Type (2025-2030) & (K Units)
  • Table 99. Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Type (2019-2024) & (US$ Million)
  • Table 100. Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Type (2025-2030) & (US$ Million)
  • Table 101. Middle East, Africa and Latin America Natural Antitumor Drug Sales by Application (2019-2024) & (K Units)
  • Table 102. Middle East, Africa and Latin America Natural Antitumor Drug Sales by Application (2025-2030) & (K Units)
  • Table 103. Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Application (2019-2024) & (US$ Million)
  • Table 104. Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Application (2025-2030) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America Natural Antitumor Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 106. Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Country (2019-2024) & (US$ Million)
  • Table 107. Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Country (2025-2030) & (US$ Million)
  • Table 108. Middle East, Africa and Latin America Natural Antitumor Drug Sales by Country (2019-2024) & (K Units)
  • Table 109. Middle East, Africa and Latin America Natural Antitumor Drug Sales by Country (2025-2030) & (K Units)
  • Table 110. Pfizer Company Information
  • Table 111. Pfizer Description and Major Businesses
  • Table 112. Pfizer Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 113. Pfizer Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 114. Pfizer Recent Developments
  • Table 115. Sanofi US Company Information
  • Table 116. Sanofi US Description and Major Businesses
  • Table 117. Sanofi US Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 118. Sanofi US Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 119. Sanofi US Recent Developments
  • Table 120. Sun Pharma Company Information
  • Table 121. Sun Pharma Description and Major Businesses
  • Table 122. Sun Pharma Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 123. Sun Pharma Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 124. Sun Pharma Recent Developments
  • Table 125. Oasmia Company Information
  • Table 126. Oasmia Description and Major Businesses
  • Table 127. Oasmia Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 128. Oasmia Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 129. Oasmia Recent Developments
  • Table 130. Indena Company Information
  • Table 131. Indena Description and Major Businesses
  • Table 132. Indena Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 133. Indena Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 134. Indena Recent Developments
  • Table 135. Bristol-Myers Squibb Company Company Information
  • Table 136. Bristol-Myers Squibb Company Description and Major Businesses
  • Table 137. Bristol-Myers Squibb Company Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 138. Bristol-Myers Squibb Company Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 139. Bristol-Myers Squibb Company Recent Developments
  • Table 140. PierreFabre Company Information
  • Table 141. PierreFabre Description and Major Businesses
  • Table 142. PierreFabre Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 143. PierreFabre Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 144. PierreFabre Recent Developments
  • Table 145. Qilu Pharmaceutical Company Information
  • Table 146. Qilu Pharmaceutical Description and Major Businesses
  • Table 147. Qilu Pharmaceutical Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 148. Qilu Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 149. Qilu Pharmaceutical Recent Developments
  • Table 150. Fuxing Medicine Company Information
  • Table 151. Fuxing Medicine Description and Major Businesses
  • Table 152. Fuxing Medicine Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 153. Fuxing Medicine Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 154. Fuxing Medicine Recent Developments
  • Table 155. Yuekang Pharmaceutical Company Information
  • Table 156. Yuekang Pharmaceutical Description and Major Businesses
  • Table 157. Yuekang Pharmaceutical Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 158. Yuekang Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 159. Yuekang Pharmaceutical Recent Developments
  • Table 160. Hengrui Medicine Company Information
  • Table 161. Hengrui Medicine Description and Major Businesses
  • Table 162. Hengrui Medicine Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 163. Hengrui Medicine Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 164. Hengrui Medicine Recent Developments
  • Table 165. Huiyu Pharmaceutical Company Information
  • Table 166. Huiyu Pharmaceutical Description and Major Businesses
  • Table 167. Huiyu Pharmaceutical Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 168. Huiyu Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 169. Huiyu Pharmaceutical Recent Developments
  • Table 170. Zhendong Pharmaceutical Company Information
  • Table 171. Zhendong Pharmaceutical Description and Major Businesses
  • Table 172. Zhendong Pharmaceutical Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 173. Zhendong Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 174. Zhendong Pharmaceutical Recent Developments
  • Table 175. Chinese Academy of Sciences Company Information
  • Table 176. Chinese Academy of Sciences Description and Major Businesses
  • Table 177. Chinese Academy of Sciences Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 178. Chinese Academy of Sciences Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 179. Chinese Academy of Sciences Recent Developments
  • Table 180. Hainan Changchun Pharmaceutical Co., Ltd. Company Information
  • Table 181. Hainan Changchun Pharmaceutical Co., Ltd. Description and Major Businesses
  • Table 182. Hainan Changchun Pharmaceutical Co., Ltd. Natural Antitumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 183. Hainan Changchun Pharmaceutical Co., Ltd. Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 184. Hainan Changchun Pharmaceutical Co., Ltd. Recent Developments
  • Table 185. Key Raw Materials Lists
  • Table 186. Raw Materials Key Suppliers Lists
  • Table 187. Natural Antitumor Drug Distributors List
  • Table 188. Natural Antitumor Drug Customers List
  • Table 189. Natural Antitumor Drug Market Trends
  • Table 190. Natural Antitumor Drug Market Drivers
  • Table 191. Natural Antitumor Drug Market Challenges
  • Table 192. Natural Antitumor Drug Market Restraints
  • Table 193. Research Programs/Design for This Report
  • Table 194. Key Data Information from Secondary Sources
  • Table 195. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Natural Antitumor Drug Product Picture
  • Figure 2. Global Natural Antitumor Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 3. Global Natural Antitumor Drug Market Share by Type in 2023 & 2030
  • Figure 4. Taxanes Product Picture
  • Figure 5. Catharanthus Roseus Product Picture
  • Figure 6. Podophyllotoxins Product Picture
  • Figure 7. Colchicines Product Picture
  • Figure 8. Others Product Picture
  • Figure 9. Global Natural Antitumor Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 10. Global Natural Antitumor Drug Market Share by Application in 2023 & 2030
  • Figure 11. Breast Cancer
  • Figure 12. Stomach Cancer
  • Figure 13. Ovarian Cancer
  • Figure 14. Lung Cancer
  • Figure 15. Testicular Cancer
  • Figure 16. Cervical Cancer
  • Figure 17. Endometrial Cancer
  • Figure 18. Prostate Cancer
  • Figure 19. Bladder Cancer
  • Figure 20. Others
  • Figure 21. Natural Antitumor Drug Report Years Considered
  • Figure 22. Global Natural Antitumor Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
  • Figure 23. Global Natural Antitumor Drug Revenue 2019-2030 (US$ Million)
  • Figure 24. Global Natural Antitumor Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
  • Figure 25. Global Natural Antitumor Drug Revenue Market Share by Region (2019-2030)
  • Figure 26. Global Natural Antitumor Drug Sales 2019-2030 ((K Units)
  • Figure 27. Global Natural Antitumor Drug Sales Market Share by Region (2019-2030)
  • Figure 28. US & Canada Natural Antitumor Drug Sales YoY (2019-2030) & (K Units)
  • Figure 29. US & Canada Natural Antitumor Drug Revenue YoY (2019-2030) & (US$ Million)
  • Figure 30. Europe Natural Antitumor Drug Sales YoY (2019-2030) & (K Units)
  • Figure 31. Europe Natural Antitumor Drug Revenue YoY (2019-2030) & (US$ Million)
  • Figure 32. China Natural Antitumor Drug Sales YoY (2019-2030) & (K Units)
  • Figure 33. China Natural Antitumor Drug Revenue YoY (2019-2030) & (US$ Million)
  • Figure 34. Asia (excluding China) Natural Antitumor Drug Sales YoY (2019-2030) & (K Units)
  • Figure 35. Asia (excluding China) Natural Antitumor Drug Revenue YoY (2019-2030) & (US$ Million)
  • Figure 36. Middle East, Africa and Latin America Natural Antitumor Drug Sales YoY (2019-2030) & (K Units)
  • Figure 37. Middle East, Africa and Latin America Natural Antitumor Drug Revenue YoY (2019-2030) & (US$ Million)
  • Figure 38. The Natural Antitumor Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
  • Figure 39. The Top 5 and 10 Largest Manufacturers of Natural Antitumor Drug in the World: Market Share by Natural Antitumor Drug Revenue in 2023
  • Figure 40. Global Natural Antitumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
  • Figure 41. Global Natural Antitumor Drug Sales Market Share by Type (2019-2030)
  • Figure 42. Global Natural Antitumor Drug Revenue Market Share by Type (2019-2030)
  • Figure 43. Global Natural Antitumor Drug Sales Market Share by Application (2019-2030)
  • Figure 44. Global Natural Antitumor Drug Revenue Market Share by Application (2019-2030)
  • Figure 45. US & Canada Natural Antitumor Drug Sales Market Share by Type (2019-2030)
  • Figure 46. US & Canada Natural Antitumor Drug Revenue Market Share by Type (2019-2030)
  • Figure 47. US & Canada Natural Antitumor Drug Sales Market Share by Application (2019-2030)
  • Figure 48. US & Canada Natural Antitumor Drug Revenue Market Share by Application (2019-2030)
  • Figure 49. US & Canada Natural Antitumor Drug Revenue Share by Country (2019-2030)
  • Figure 50. US & Canada Natural Antitumor Drug Sales Share by Country (2019-2030)
  • Figure 51. U.S. Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 52. Canada Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 53. Europe Natural Antitumor Drug Sales Market Share by Type (2019-2030)
  • Figure 54. Europe Natural Antitumor Drug Revenue Market Share by Type (2019-2030)
  • Figure 55. Europe Natural Antitumor Drug Sales Market Share by Application (2019-2030)
  • Figure 56. Europe Natural Antitumor Drug Revenue Market Share by Application (2019-2030)
  • Figure 57. Europe Natural Antitumor Drug Revenue Share by Country (2019-2030)
  • Figure 58. Europe Natural Antitumor Drug Sales Share by Country (2019-2030)
  • Figure 59. Germany Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 60. France Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 61. U.K. Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 62. Italy Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 63. Netherlands Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 64. China Natural Antitumor Drug Sales Market Share by Type (2019-2030)
  • Figure 65. China Natural Antitumor Drug Revenue Market Share by Type (2019-2030)
  • Figure 66. China Natural Antitumor Drug Sales Market Share by Application (2019-2030)
  • Figure 67. China Natural Antitumor Drug Revenue Market Share by Application (2019-2030)
  • Figure 68. Asia Natural Antitumor Drug Sales Market Share by Type (2019-2030)
  • Figure 69. Asia Natural Antitumor Drug Revenue Market Share by Type (2019-2030)
  • Figure 70. Asia Natural Antitumor Drug Sales Market Share by Application (2019-2030)
  • Figure 71. Asia Natural Antitumor Drug Revenue Market Share by Application (2019-2030)
  • Figure 72. Asia Natural Antitumor Drug Revenue Share by Region (2019-2030)
  • Figure 73. Asia Natural Antitumor Drug Sales Share by Region (2019-2030)
  • Figure 74. Japan Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 75. South Korea Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 76. China Taiwan Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 77. Southeast Asia Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 78. India Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 79. Middle East, Africa and Latin America Natural Antitumor Drug Sales Market Share by Type (2019-2030)
  • Figure 80. Middle East, Africa and Latin America Natural Antitumor Drug Revenue Market Share by Type (2019-2030)
  • Figure 81. Middle East, Africa and Latin America Natural Antitumor Drug Sales Market Share by Application (2019-2030)
  • Figure 82. Middle East, Africa and Latin America Natural Antitumor Drug Revenue Market Share by Application (2019-2030)
  • Figure 83. Middle East, Africa and Latin America Natural Antitumor Drug Revenue Share by Country (2019-2030)
  • Figure 84. Middle East, Africa and Latin America Natural Antitumor Drug Sales Share by Country (2019-2030)
  • Figure 85. Brazil Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 86. Mexico Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 87. Turkey Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 88. Israel Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 89. GCC Countries Natural Antitumor Drug Revenue (2019-2030) & (US$ Million)
  • Figure 90. Natural Antitumor Drug Value Chain
  • Figure 91. Natural Antitumor Drug Production Process
  • Figure 92. Channels of Distribution
  • Figure 93. Distributors Profiles
  • Figure 94. Bottom-up and Top-down Approaches for This Report
  • Figure 95. Data Triangulation
  • Figure 96. Key Executives Interviewed
目次

This research report focuses on the Natural Antitumor Drug Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Natural Antitumor Drug Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Natural Antitumor Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
    • 1.2.2 Taxanes
    • 1.2.3 Catharanthus Roseus
    • 1.2.4 Podophyllotoxins
    • 1.2.5 Colchicines
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Natural Antitumor Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
    • 1.3.2 Breast Cancer
    • 1.3.3 Stomach Cancer
    • 1.3.4 Ovarian Cancer
    • 1.3.5 Lung Cancer
    • 1.3.6 Testicular Cancer
    • 1.3.7 Cervical Cancer
    • 1.3.8 Endometrial Cancer
    • 1.3.9 Prostate Cancer
    • 1.3.10 Bladder Cancer
    • 1.3.11 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Natural Antitumor Drug Sales Estimates and Forecasts 2019-2030
  • 2.2 Global Natural Antitumor Drug Revenue by Region
    • 2.2.1 Global Natural Antitumor Drug Revenue by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Global Natural Antitumor Drug Revenue by Region (2019-2024)
    • 2.2.3 Global Natural Antitumor Drug Revenue by Region (2025-2030)
    • 2.2.4 Global Natural Antitumor Drug Revenue Market Share by Region (2019-2030)
  • 2.3 Global Natural Antitumor Drug Sales Estimates and Forecasts 2019-2030
  • 2.4 Global Natural Antitumor Drug Sales by Region
    • 2.4.1 Global Natural Antitumor Drug Sales by Region: 2019 VS 2023 VS 2030
    • 2.4.2 Global Natural Antitumor Drug Sales by Region (2019-2024)
    • 2.4.3 Global Natural Antitumor Drug Sales by Region (2025-2030)
    • 2.4.4 Global Natural Antitumor Drug Sales Market Share by Region (2019-2030)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global Natural Antitumor Drug Sales by Manufacturers
    • 3.1.1 Global Natural Antitumor Drug Sales by Manufacturers (2019-2024)
    • 3.1.2 Global Natural Antitumor Drug Sales Market Share by Manufacturers (2019-2024)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Natural Antitumor Drug in 2023
  • 3.2 Global Natural Antitumor Drug Revenue by Manufacturers
    • 3.2.1 Global Natural Antitumor Drug Revenue by Manufacturers (2019-2024)
    • 3.2.2 Global Natural Antitumor Drug Revenue Market Share by Manufacturers (2019-2024)
    • 3.2.3 Global Top 10 and Top 5 Companies by Natural Antitumor Drug Revenue in 2023
  • 3.3 Global Key Players of Natural Antitumor Drug, Industry Ranking, 2022 VS 2023 VS 2024
  • 3.4 Global Natural Antitumor Drug Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Natural Antitumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Natural Antitumor Drug, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Natural Antitumor Drug, Product Offered and Application
  • 3.8 Global Key Manufacturers of Natural Antitumor Drug, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Natural Antitumor Drug Sales by Type
    • 4.1.1 Global Natural Antitumor Drug Historical Sales by Type (2019-2024)
    • 4.1.2 Global Natural Antitumor Drug Forecasted Sales by Type (2025-2030)
    • 4.1.3 Global Natural Antitumor Drug Sales Market Share by Type (2019-2030)
  • 4.2 Global Natural Antitumor Drug Revenue by Type
    • 4.2.1 Global Natural Antitumor Drug Historical Revenue by Type (2019-2024)
    • 4.2.2 Global Natural Antitumor Drug Forecasted Revenue by Type (2025-2030)
    • 4.2.3 Global Natural Antitumor Drug Revenue Market Share by Type (2019-2030)
  • 4.3 Global Natural Antitumor Drug Price by Type
    • 4.3.1 Global Natural Antitumor Drug Price by Type (2019-2024)
    • 4.3.2 Global Natural Antitumor Drug Price Forecast by Type (2025-2030)

5 Market Size by Application

  • 5.1 Global Natural Antitumor Drug Sales by Application
    • 5.1.1 Global Natural Antitumor Drug Historical Sales by Application (2019-2024)
    • 5.1.2 Global Natural Antitumor Drug Forecasted Sales by Application (2025-2030)
    • 5.1.3 Global Natural Antitumor Drug Sales Market Share by Application (2019-2030)
  • 5.2 Global Natural Antitumor Drug Revenue by Application
    • 5.2.1 Global Natural Antitumor Drug Historical Revenue by Application (2019-2024)
    • 5.2.2 Global Natural Antitumor Drug Forecasted Revenue by Application (2025-2030)
    • 5.2.3 Global Natural Antitumor Drug Revenue Market Share by Application (2019-2030)
  • 5.3 Global Natural Antitumor Drug Price by Application
    • 5.3.1 Global Natural Antitumor Drug Price by Application (2019-2024)
    • 5.3.2 Global Natural Antitumor Drug Price Forecast by Application (2025-2030)

6 US & Canada

  • 6.1 US & Canada Natural Antitumor Drug Market Size by Type
    • 6.1.1 US & Canada Natural Antitumor Drug Sales by Type (2019-2030)
    • 6.1.2 US & Canada Natural Antitumor Drug Revenue by Type (2019-2030)
  • 6.2 US & Canada Natural Antitumor Drug Market Size by Application
    • 6.2.1 US & Canada Natural Antitumor Drug Sales by Application (2019-2030)
    • 6.2.2 US & Canada Natural Antitumor Drug Revenue by Application (2019-2030)
  • 6.3 US & Canada Natural Antitumor Drug Market Size by Country
    • 6.3.1 US & Canada Natural Antitumor Drug Revenue by Country: 2019 VS 2023 VS 2030
    • 6.3.2 US & Canada Natural Antitumor Drug Sales by Country (2019-2030)
    • 6.3.3 US & Canada Natural Antitumor Drug Revenue by Country (2019-2030)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Natural Antitumor Drug Market Size by Type
    • 7.1.1 Europe Natural Antitumor Drug Sales by Type (2019-2030)
    • 7.1.2 Europe Natural Antitumor Drug Revenue by Type (2019-2030)
  • 7.2 Europe Natural Antitumor Drug Market Size by Application
    • 7.2.1 Europe Natural Antitumor Drug Sales by Application (2019-2030)
    • 7.2.2 Europe Natural Antitumor Drug Revenue by Application (2019-2030)
  • 7.3 Europe Natural Antitumor Drug Market Size by Country
    • 7.3.1 Europe Natural Antitumor Drug Revenue by Country: 2019 VS 2023 VS 2030
    • 7.3.2 Europe Natural Antitumor Drug Sales by Country (2019-2030)
    • 7.3.3 Europe Natural Antitumor Drug Revenue by Country (2019-2030)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Netherlands

8 China

  • 8.1 China Natural Antitumor Drug Market Size
    • 8.1.1 China Natural Antitumor Drug Sales (2019-2030)
    • 8.1.2 China Natural Antitumor Drug Revenue (2019-2030)
  • 8.2 China Natural Antitumor Drug Market Size by Application
    • 8.2.1 China Natural Antitumor Drug Sales by Application (2019-2030)
    • 8.2.2 China Natural Antitumor Drug Revenue by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Natural Antitumor Drug Market Size by Type
    • 9.1.1 Asia Natural Antitumor Drug Sales by Type (2019-2030)
    • 9.1.2 Asia Natural Antitumor Drug Revenue by Type (2019-2030)
  • 9.2 Asia Natural Antitumor Drug Market Size by Application
    • 9.2.1 Asia Natural Antitumor Drug Sales by Application (2019-2030)
    • 9.2.2 Asia Natural Antitumor Drug Revenue by Application (2019-2030)
  • 9.3 Asia Natural Antitumor Drug Sales by Region
    • 9.3.1 Asia Natural Antitumor Drug Revenue by Region: 2019 VS 2023 VS 2030
    • 9.3.2 Asia Natural Antitumor Drug Revenue by Region (2019-2030)
    • 9.3.3 Asia Natural Antitumor Drug Sales by Region (2019-2030)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Natural Antitumor Drug Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Natural Antitumor Drug Sales by Type (2019-2030)
    • 10.1.2 Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Type (2019-2030)
  • 10.2 Middle East, Africa and Latin America Natural Antitumor Drug Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Natural Antitumor Drug Sales by Application (2019-2030)
    • 10.2.2 Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Application (2019-2030)
  • 10.3 Middle East, Africa and Latin America Natural Antitumor Drug Sales by Country
    • 10.3.1 Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Country: 2019 VS 2023 VS 2030
    • 10.3.2 Middle East, Africa and Latin America Natural Antitumor Drug Revenue by Country (2019-2030)
    • 10.3.3 Middle East, Africa and Latin America Natural Antitumor Drug Sales by Country (2019-2030)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Company Information
    • 11.1.2 Pfizer Overview
    • 11.1.3 Pfizer Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.1.4 Pfizer Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Pfizer Recent Developments
  • 11.2 Sanofi US
    • 11.2.1 Sanofi US Company Information
    • 11.2.2 Sanofi US Overview
    • 11.2.3 Sanofi US Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.2.4 Sanofi US Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Sanofi US Recent Developments
  • 11.3 Sun Pharma
    • 11.3.1 Sun Pharma Company Information
    • 11.3.2 Sun Pharma Overview
    • 11.3.3 Sun Pharma Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.3.4 Sun Pharma Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Sun Pharma Recent Developments
  • 11.4 Oasmia
    • 11.4.1 Oasmia Company Information
    • 11.4.2 Oasmia Overview
    • 11.4.3 Oasmia Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.4.4 Oasmia Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Oasmia Recent Developments
  • 11.5 Indena
    • 11.5.1 Indena Company Information
    • 11.5.2 Indena Overview
    • 11.5.3 Indena Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.5.4 Indena Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Indena Recent Developments
  • 11.6 Bristol-Myers Squibb Company
    • 11.6.1 Bristol-Myers Squibb Company Company Information
    • 11.6.2 Bristol-Myers Squibb Company Overview
    • 11.6.3 Bristol-Myers Squibb Company Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.6.4 Bristol-Myers Squibb Company Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Bristol-Myers Squibb Company Recent Developments
  • 11.7 PierreFabre
    • 11.7.1 PierreFabre Company Information
    • 11.7.2 PierreFabre Overview
    • 11.7.3 PierreFabre Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.7.4 PierreFabre Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 PierreFabre Recent Developments
  • 11.8 Qilu Pharmaceutical
    • 11.8.1 Qilu Pharmaceutical Company Information
    • 11.8.2 Qilu Pharmaceutical Overview
    • 11.8.3 Qilu Pharmaceutical Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.8.4 Qilu Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Qilu Pharmaceutical Recent Developments
  • 11.9 Fuxing Medicine
    • 11.9.1 Fuxing Medicine Company Information
    • 11.9.2 Fuxing Medicine Overview
    • 11.9.3 Fuxing Medicine Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.9.4 Fuxing Medicine Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Fuxing Medicine Recent Developments
  • 11.10 Yuekang Pharmaceutical
    • 11.10.1 Yuekang Pharmaceutical Company Information
    • 11.10.2 Yuekang Pharmaceutical Overview
    • 11.10.3 Yuekang Pharmaceutical Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.10.4 Yuekang Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Yuekang Pharmaceutical Recent Developments
  • 11.11 Hengrui Medicine
    • 11.11.1 Hengrui Medicine Company Information
    • 11.11.2 Hengrui Medicine Overview
    • 11.11.3 Hengrui Medicine Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.11.4 Hengrui Medicine Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Hengrui Medicine Recent Developments
  • 11.12 Huiyu Pharmaceutical
    • 11.12.1 Huiyu Pharmaceutical Company Information
    • 11.12.2 Huiyu Pharmaceutical Overview
    • 11.12.3 Huiyu Pharmaceutical Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.12.4 Huiyu Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Huiyu Pharmaceutical Recent Developments
  • 11.13 Zhendong Pharmaceutical
    • 11.13.1 Zhendong Pharmaceutical Company Information
    • 11.13.2 Zhendong Pharmaceutical Overview
    • 11.13.3 Zhendong Pharmaceutical Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.13.4 Zhendong Pharmaceutical Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 Zhendong Pharmaceutical Recent Developments
  • 11.14 Chinese Academy of Sciences
    • 11.14.1 Chinese Academy of Sciences Company Information
    • 11.14.2 Chinese Academy of Sciences Overview
    • 11.14.3 Chinese Academy of Sciences Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.14.4 Chinese Academy of Sciences Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.14.5 Chinese Academy of Sciences Recent Developments
  • 11.15 Hainan Changchun Pharmaceutical Co., Ltd.
    • 11.15.1 Hainan Changchun Pharmaceutical Co., Ltd. Company Information
    • 11.15.2 Hainan Changchun Pharmaceutical Co., Ltd. Overview
    • 11.15.3 Hainan Changchun Pharmaceutical Co., Ltd. Natural Antitumor Drug Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.15.4 Hainan Changchun Pharmaceutical Co., Ltd. Natural Antitumor Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.15.5 Hainan Changchun Pharmaceutical Co., Ltd. Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Natural Antitumor Drug Industry Chain Analysis
  • 12.2 Natural Antitumor Drug Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Natural Antitumor Drug Production Mode & Process
  • 12.4 Natural Antitumor Drug Sales and Marketing
    • 12.4.1 Natural Antitumor Drug Sales Channels
    • 12.4.2 Natural Antitumor Drug Distributors
  • 12.5 Natural Antitumor Drug Customers

13 Market Dynamics

  • 13.1 Natural Antitumor Drug Industry Trends
  • 13.2 Natural Antitumor Drug Market Drivers
  • 13.3 Natural Antitumor Drug Market Challenges
  • 13.4 Natural Antitumor Drug Market Restraints

14 Key Findings in The Global Natural Antitumor Drug Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer